Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Journal of International Oncology ; (12): 269-272, 2018.
Article in Chinese | WPRIM | ID: wpr-693492

ABSTRACT

Objective To analyze the prognostic implications of second-line double drug regimens for advanced non-small cell lung cancer (NSCLC) patients and related factors.Methods Eighty patients with advanced NSCLC who were accepted from January 2014 to December 2016 in our hospital were chosen as the research objects.The patients were randomly divided into two groups using the random number table method,namely single drug group (n =40) and double drug group (n =40).The patients in single drug group were treated with docetaxel or pemetrexed,and the patients in double drug group were treated with docetaxel,pemetrexed,vinorelbine or paclitaxel combined with platinum (cisplatin).The effects of patients in the two groups were compared and the factors affecting the prognosis of the patients were analyzed.Results The remission rate in the double drug group was significantly higher than that in the single drug group (45.0% vs.20.0%;x2 =4.493,P =0.021).The results of single factor analysis for patients in double drug group showed that pathological type (x2 =7.511,P =0.023),time from first-line treatment to second-line treatment (x2 =6.412,P =0.041),second-line baseline TNM stage (x2 =4.022,P =0.045),second-line cycle number (x2 =5.065,P =0.027),leukopenia (x2 =4.852,P =0.033) and neuron specific enolase (x2 =9.243,P =0.002) were the main prognostic factors of the second-line chemotherapy.The results of multivariate analysis for patients in double drug group showed that time from first-line treatment to second-line treatment (OR =3.511,95 % CI:1.486-3.602,P =0.033),second-line baseline TNM stage (OR =1.623,95 % CI:1.127-2.119,P =0.027),second-line cycle number (OR =2.208,95 % CI:1.589-2.827,P =0.014) and neuron specific enolase (OR =1.960,95% CI:1.209-2.773,P =0.025) were independent prognostic factors.Conclusion The remission effect of double second-line treatment scheme based on platinum for patients with NSCLC is good,and the time form first-line treatment to second-line treatment,second-line baseline TNM stage,second-line cycle number and neuron specific enolase are independent prognostic factors.

2.
Parenteral & Enteral Nutrition ; (6)2004.
Article in Chinese | WPRIM | ID: wpr-564171

ABSTRACT

Objective: To investigate the influence of the closed re-infusion of intestinal juice and EN on the treatment of intestinal fistula.Methods: The study group was composed of 21 patients of intestinal fistula from October 2004 to December 2006.The fistulae was in the 50 cm of the proximate jejunum and caused by trauma and operatin.The leak amount of intestinal juice was more than 1 000 mL.The protein level in serum and the absorption rates of the glucose,fat and nitrogen after the reinfusion of the intestinal juice were measured.Resutls: The protein level in serum and the absorption rates of the glusose,fat and nitrogen was increased after the re-infusion of the intestinal juice.Conclusion: The absorption of the glucose,fat and nitrogen in EN and the protein level in serum can be increased after the closed re-infusion of the intestinal juice.

SELECTION OF CITATIONS
SEARCH DETAIL